May 28 2024University of Saskatchewan A University of Saskatchewan research team's discovery of the additional health benefits of an appetite-suppressing protein has doubled the potential for scientists to find new avenues for treating obesity and metabolic disorders in animals and people.
While the lipid-lowering effect of nesfatin-1 was previously reported, Unniappan said identifying NLP and understanding its lipid-lowering capabilities in human cells represent new advancements in the field of endocrinology. Unniappan and his research team have been at the forefront of nesfatin-1 research. Discovered in 2006 by a group of researchers in Japan, nesfatin-1 was initially recognized for its ability to suppress food intake.
Discovering such results-;that administering NLP reduces lipid levels, while disrupting its production alters lipid metabolism-;reinforces its pivotal role in metabolic regulation.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New research presents 'mini-brains' that could advance Alzheimer's treatmentUsing an innovative new method, a University of Saskatchewan (USask) researcher is building tiny pseudo-organs from stem cells to help diagnose and treat Alzheimer's.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers explore new cell target for cystic fibrosis treatmentA team of University of Saskatchewan (USask) researchers are exploring the role of a newly identified cell type in cystic fibrosis (CF), which could lead to effective new types of treatment.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers identify promising protein candidate for metabolic disease treatmentUniversity of Saskatchewan (USask) research, which has been published in Communications Biology, highlights the discovery of the lipid-lowering effects of nesfatin-1-like peptide (NLP). This newly identified peptide—or small protein—is a close relative of nesfatin-1 (NESF-1), which regulates feed intake and body weight.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers uncover molecular mechanism of natural killer cell dysfunction in Hodgkin lymphomaA multidisciplinary research team comprising the Griffith Institute for Drug Discovery (GRIDD, Griffith University), Mater Research (based at the Translational Research Institute) and The University of Queensland's (UQ) Frazer Institute, have made a breakthrough discovery in the body's immune response to the blood cancer Hodgkin Lymphoma.
Source: medical_xpress - 🏆 101. / 51 Read more »